Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Martinez-Ordoñez A, Duran A, Ruiz-Martinez M, Cid-Diaz T, Zhang X, Han Q, et al. Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer Cell. 2023;41(2):252-271.e9.

Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. "Stromal cells in prostate cancer pathobiology: friends or foes?". Br J Cancer. 2023;128(6):930-939.

Hissong E, Zhao L, Shi J. Clinicopathologic and Molecular Features of Pancreatic Ductal Adenocarcinomas Harboring Alterations in COMPASS-like Complex Genes. Arch Pathol Lab Med. 2023;147(9):1050-1059.

Munoz-Zuluaga C, Zhao Z, Wang F, Greenblatt MB, Yang HS. Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine. Clin Chem. 2023;69(8):939-940.

Bajema IM, Balow JE, Haas M, Jayne D, Lightstone L, Rovin BH, et al. Update on scoring and providing evidence basis for assessing pathology in lupus nephritis. Kidney Int. 2023;103(5):813-816.

Bharati J, Bijol V, Salvatore S, Jhaveri KD, Sharma P. The Case | A benign reason behind a malignant finding. Kidney Int. 2023;103(2):433-434.

Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023;141(8):904-916.

Noch EK, Palma LN, Yim I, Bullen N, Qiu Y, Ravichandran H, et al. Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. Neuro Oncol. 2023;25(12):2165-2176.

Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, et al. Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clin Cancer Res. 2023;29(15):2933-2943.

Camacho A, Salah F, Bay CP, Waring J, Umeton R, Hirsch MS, et al. PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection. BJUI Compass. 2023;4(4):473-481.